Lyrica Suicide Lawsuits Considered Due to Possible Link Between Pregabalin And Fatal Side Effects
The drug Lyrica, used to treat fibromyalgia pain, diabetic nerve pain, spinal cord injury pain and pain after shingles, has been linked to an increased risk of suicidal thoughts or behavior. Lyrica, which is a brand name for pregabalin, also has been approved for the treatment of partial onset seizures in adults with epilepsy who take one or more drugs for seizures.
A derivative of the drug Neurontin, Lyrica has been aggressively marketed for a number of "off-label" uses. This means that some people are using Lyrica to treat conditions such as:
- Pain relief
- Neuropathic pain
- Nystagmus (involuntary eye movement)
- Complex regional pain syndrome
- Bipolar disorder
- Hot flashes related to menopause
- Idiopathic subjective tinnitus
Off-label Use and Lyrica
While doctors may prescribe drugs like Lyrica for off-label use, a drug manufacturer cannot market or promote a drug for a use not approved by the Food and Drug Administration. In 2009, a subsidiary of Pfizer, Lyrica's manufacturer, pleaded guilty to misbranding Lyrica and three other drugs.
In 2008, the FDA ordered the makers of epilepsy drugs, including Lyrica manufacturer Pfizer, to add a warning to the label about the higher risk of suicidal thoughts and behaviors linked to the drugs and a guide for patients to understand the risk.
People who have lost loved ones who were treated with the antiepileptic medication should take steps to protect their rights by discussing their options with a Lyrica suicide attorney. If you or a loved one attempted suicide after taking Lyrica, talk to a doctor immediately. Too much is at stake to ignore any dangerous side effects of Lyrica. The FDA found in an independent analysis that pregabalin and other anticonvulsant drugs can increase suicidal thoughts in people using the drug.
Neurontin, a drug similar to Lyrica and also marketed by Pfizer, also is linked to an elevated risk of suicidal thoughts and behavior. In March 2010, a jury ordered Pfizer to pay $142.1 million in damages after the world's largest drug company was found in violation of U.S. racketeering laws in the marketing Neurontin for unapproved uses. Pfizer faces other Neurontin lawsuits claiming the company knew the drug posed a suicide risk but Pfizer failed to disclose it to patients and doctors.
Contact a Lyrica suicide attorney today
For more information about whether you need to pursue a Lyrica suicide lawsuit, call 214-618-8222 or contact us online. At the Law Offices of Skip Simpson, we offer free and confidential consultations for all potential clients. Our goal is to help clients obtain compensation and closure for their losses, but we also realize your case is important for other families who are going through a similar ordeal. We want to help you hold negligent individuals and businesses accountable for their actions - and send a message that such behavior will not be tolerated.